[SIME] YoY TTM Result on 31-Dec-2003 [#2]

Stock
[SIME] SIME DARBY BHD
Announcement Date
24-Feb-2004
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2004
Quarter
31-Dec-2003 [#2]
Profit Trend
QoQ- -1.42%
YoY- 5.94%
Quarter Report
Latest QR
Upcoming QR
SIME's Result
SIME's Financial Summary
View:
Show?
TTM Result
31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 31/12/00 CAGR
Revenue 21,855,831 19,924,356 16,512,144 13,910,408 13,319,180 11,582,775 11,670,959 11.01%
PBT 2,407,988 1,506,967 1,238,220 1,303,210 1,249,785 1,117,163 1,310,693 10.66%
Tax -509,543 -426,706 -476,725 -467,226 -460,705 -448,524 -502,346 0.23%
NP 1,898,445 1,080,261 761,495 835,984 789,080 668,639 808,347 15.28%
-
NP to SH 1,770,247 986,312 761,495 835,984 789,080 668,639 808,347 13.94%
-
Tax Rate 21.16% 28.32% 38.50% 35.85% 36.86% 40.15% 38.33% -
Total Cost 19,957,386 18,844,095 15,750,649 13,074,424 12,530,100 10,914,136 10,862,612 10.66%
-
Net Worth 7,425,285 9,296,227 7,586,639 8,095,625 7,280,214 6,816,918 6,598,408 1.98%
Dividend
31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 31/12/00 CAGR
Div 616,001 620,864 612,016 579,024 522,150 430,637 511,029 3.16%
Div Payout % 34.80% 62.95% 80.37% 69.26% 66.17% 64.41% 63.22% -
Equity
31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 31/12/00 CAGR
Net Worth 7,425,285 9,296,227 7,586,639 8,095,625 7,280,214 6,816,918 6,598,408 1.98%
NOSH 2,475,095 2,414,604 2,312,999 2,313,035 2,318,539 2,334,561 2,323,383 1.05%
Ratio Analysis
31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 31/12/00 CAGR
NP Margin 8.69% 5.42% 4.61% 6.01% 5.92% 5.77% 6.93% -
ROE 23.84% 10.61% 10.04% 10.33% 10.84% 9.81% 12.25% -
Per Share
31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 31/12/00 CAGR
RPS 883.03 825.16 713.88 601.39 574.46 496.14 502.33 9.85%
EPS 71.52 40.85 32.92 36.14 34.03 28.64 34.79 12.75%
DPS 25.00 26.00 26.46 25.00 22.50 18.50 22.00 2.15%
NAPS 3.00 3.85 3.28 3.50 3.14 2.92 2.84 0.91%
Adjusted Per Share Value based on latest NOSH - 2,313,035
31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 31/12/00 CAGR
RPS 319.64 291.39 241.49 203.44 194.79 169.40 170.69 11.01%
EPS 25.89 14.42 11.14 12.23 11.54 9.78 11.82 13.95%
DPS 9.01 9.08 8.95 8.47 7.64 6.30 7.47 3.17%
NAPS 1.0859 1.3596 1.1095 1.184 1.0647 0.997 0.965 1.98%
Price Multiplier on Financial Quarter End Date
31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 31/12/00 CAGR
Date 29/12/06 30/12/05 31/12/04 31/12/03 31/12/02 31/12/01 26/12/00 -
Price 7.20 6.15 6.00 5.20 4.96 4.90 4.76 -
P/RPS 0.82 0.75 0.84 0.86 0.86 0.99 0.95 -2.42%
P/EPS 10.07 15.06 18.22 14.39 14.57 17.11 13.68 -4.97%
EY 9.93 6.64 5.49 6.95 6.86 5.85 7.31 5.23%
DY 3.47 4.23 4.41 4.81 4.54 3.78 4.62 -4.65%
P/NAPS 2.40 1.60 1.83 1.49 1.58 1.68 1.68 6.12%
Price Multiplier on Announcement Date
31/12/06 31/12/05 31/12/04 31/12/03 31/12/02 31/12/01 31/12/00 CAGR
Date 28/02/07 28/02/06 28/02/05 24/02/04 27/02/03 26/02/02 28/02/01 -
Price 7.80 6.20 6.00 5.80 5.15 4.98 4.80 -
P/RPS 0.88 0.75 0.84 0.96 0.90 1.00 0.96 -1.43%
P/EPS 10.91 15.18 18.22 16.05 15.13 17.39 13.80 -3.83%
EY 9.17 6.59 5.49 6.23 6.61 5.75 7.25 3.99%
DY 3.21 4.19 4.41 4.31 4.37 3.71 4.58 -5.74%
P/NAPS 2.60 1.61 1.83 1.66 1.64 1.71 1.69 7.44%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment